Immunocore logo

Immunocore

IMCR | NASDAQ
Chart Builder DCF Calculator
$32.20
+$0.02 (+0.06%)
Sep 22, 2026, 10:39 AM ET · Market open

Market Data

Market Cap
$1.64B
Enterprise Value
$1.19B
Beta
0.74
Average Volume
476.98K
Shares Outstanding (Diluted)
50.97M
Shares Change YoY
1.35%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US45258D1054

Price Performance

Price Change 1M
-12.3%
Price Change 3M
10.2%
Price Change 6M
6.3%
Price Change YTD
-4.7%
Price Change 1Y
-3.2%
Price Change 3Y
-38.2%
Price Change 5Y
-7.4%
1M CAGR (ann.)
-5.3%
1Y CAGR (ann.)
-3.7%
5Y CAGR (ann.)
-0.2%
All-Time CAGR
-5.1%

Valuation

PE Ratio
-169.37
Forward PE
N/A
PEG Ratio
-5.64
Forward PEG
-0.21
PS Ratio
4.05
Forward PS
3.30
PB Ratio
3.90
P/FCF Ratio
-26.16
P/Adj. FCF Ratio
-16.97
P/OCF Ratio
-28.99
EV/Sales
2.95
EV/EBIT
92.83
EV/EBITDA
73.43
EV/FCF
-19.04
Earnings Yield
-0.6%
FCF Yield
-3.8%
Adj. FCF Yield
-5.9%

Financial Health

Net Cash
$484.1M
Total Debt
$434.96M
Cash & Short-Term Investments
$880.21M
Total Assets
$1.12B
Current Ratio
4.47
Quick Ratio
4.44
Debt / Equity Ratio
1.04
Debt / EBITDA
26.83
Debt / FCF
-6.96
OCF / Debt
-0.13
Interest Coverage
-1.52
Altman Z-Score
1.65
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
98.8%
Operating Profit Margin
-4.3%
EBITDA Margin
4.0%
Net Profit Margin
-2.3%
FCF Margin
-15.5%
Adj. FCF Margin
-23.9%
SBC / Revenue
8.4%
SBC Impact (per share)
-54.2%

Returns

Return on Assets
-0.8%
Return on Equity
-2.4%
Return on Invested Capital
13.6%
Return on Capital Employed
-2.0%
Return on Tangible Assets
-0.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
28.9%
Revenue CAGR 5Y
70.4%
Revenue CAGR 10Y
38.5%
EPS CAGR 3Y
75.9%
EPS CAGR 5Y
47.0%
EPS CAGR 10Y
31.3%
FCF CAGR 3Y
-488.3%
FCF CAGR 5Y
25.2%
FCF CAGR 10Y
14.1%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
14
EPS Growth Next 3Y
561.1%
Revenue Growth Next 3Y
24.4%
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
-$0.16
EPS Growth Est (next Q)
-1117.9%
Revenue Est (next Q)
$152.61M
Revenue Growth Est (next Q)
47.2%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$39
Price Target Upside
21.2%

Cash Flow

Operating Cash Flow
$-56.34M
Free Cash Flow
$-62.53M
Adj. Free Cash Flow
$-96.42M
FCF Per Share
-$1.23
OCF Per Share
-$1.11
OCF/S Ratio
-14.0%

Income Statement

Revenue
$403.72M
Gross Profit
$399.07M
Operating Income
$-17.48M
EBITDA
$16.21M
Net Income
$-9.33M
EPS (Diluted)
-$0.19
Revenue / Employee
$770.47K
Profit / Employee
$-17.8K
Employees
524

© 2026 bestshares.com. All rights reserved.